Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Econazole/Benzydamine Pessary Phase I
NCT02720783Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Mar 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of econazole and benzydamine in vaginal candidiasis (4 arms), sponsored by Angelini Pharma. Primary endpoint: Local Adverse Drug Reactions up to 7 days. Started Mar 2016; status: completed.
02
Drugs
econazolebenzydamine
03
Conditions
vaginal candidiasis
Beyond the preview
Go deeper on NCT02720783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720783.